The emerging approach of the medication represents a major advance in the handling of type 2 diabetes. Distinct from existing drugs, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide066751.wssblogs.com/41903514/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment